drugset / Trial / NCT00531401
Study of Salirasib to Treat Non-Small Cell Lung Cancer
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine whether Salirasib is effective to shrink or prevent the growth of the tumors associated with non-small cell lung cancer in both patients who are newly diagnosed or have recurrent disease.
Timeline
- Start
- 2007-09
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salirasib | Unknown | 600 mg | — |